Cochrane Abstracts
Heparin versus normal saline for patency of arterial lines
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Heparin Versus Normal Saline for Patency of Arterial Lines." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol‐O‐methyltransferase_inhibitors_versus_active_comparators_for_levodopa‐induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_. Accessed 02 October 2023.
Heparin versus normal saline for patency of arterial lines. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol‐O‐methyltransferase_inhibitors_versus_active_comparators_for_levodopa‐induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_. Accessed October 2, 2023.
Heparin versus normal saline for patency of arterial lines. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol‐O‐methyltransferase_inhibitors_versus_active_comparators_for_levodopa‐induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_
Heparin Versus Normal Saline for Patency of Arterial Lines [Internet]. In: Cochrane Abstracts. [cited 2023 October 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol‐O‐methyltransferase_inhibitors_versus_active_comparators_for_levodopa‐induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Heparin versus normal saline for patency of arterial lines
ID - 431338
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol‐O‐methyltransferase_inhibitors_versus_active_comparators_for_levodopa‐induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
